318 related articles for article (PubMed ID: 32340370)
1. In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against
Phan TN; Baek KH; Lee N; Byun SY; Shum D; No JH
Molecules; 2020 Apr; 25(8):. PubMed ID: 32340370
[TBL] [Abstract][Full Text] [Related]
2. The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing.
Diaz-Gonzalez R; Kuhlmann FM; Galan-Rodriguez C; Madeira da Silva L; Saldivia M; Karver CE; Rodriguez A; Beverley SM; Navarro M; Pollastri MP
PLoS Negl Trop Dis; 2011 Aug; 5(8):e1297. PubMed ID: 21886855
[TBL] [Abstract][Full Text] [Related]
3. Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents.
Cogo J; Cantizani J; Cotillo I; Sangi DP; Corrêa AG; Ueda-Nakamura T; Filho BPD; Martín JJ; Nakamura CV
Bioorg Med Chem; 2018 Aug; 26(14):4065-4072. PubMed ID: 30100019
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antikinetoplastid activities of 3-substituted quinolinones derivatives.
Audisio D; Messaoudi S; Cojean S; Peyrat JF; Brion JD; Bories C; Huteau F; Loiseau PM; Alami M
Eur J Med Chem; 2012 Jun; 52():44-50. PubMed ID: 22472166
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of 9,9-dimethylxanthene tricyclics against trypanothione reductase, Trypanosoma brucei, Trypanosoma cruzi and Leishmania donovani.
Chibale K; Visser M; Yardley V; Croft SL; Fairlamb AH
Bioorg Med Chem Lett; 2000 Jun; 10(11):1147-50. PubMed ID: 10866368
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiprotozoal activity of original porphyrin precursors and derivatives.
Abada Z; Cojean S; Pomel S; Ferrié L; Akagah B; Lormier AT; Loiseau PM; Figadère B
Eur J Med Chem; 2013 Sep; 67():158-65. PubMed ID: 23851117
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of Triclisia patens and some bisbenzylisoquinoline alkaloids against Leishmania donovani and Trypanosoma brucei brucei.
del Rayo Camacho M; Phillipson JD; Croft SL; Rock P; Marshall SJ; Schiff PL
Phytother Res; 2002 Aug; 16(5):432-6. PubMed ID: 12203262
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel guttiferone A derivatives: in-vitro evaluation toward Plasmodium falciparum, Trypanosoma brucei and Leishmania donovani.
Fromentin Y; Gaboriaud-Kolar N; Lenta BN; Wansi JD; Buisson D; Mouray E; Grellier P; Loiseau PM; Lallemand MC; Michel S
Eur J Med Chem; 2013 Jul; 65():284-94. PubMed ID: 23727538
[TBL] [Abstract][Full Text] [Related]
9. Identification of
Phan TN; Park KP; Shum D; No JH
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675653
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
11. Using a non-image-based medium-throughput assay for screening compounds targeting N-myristoylation in intracellular Leishmania amastigotes.
Paape D; Bell AS; Heal WP; Hutton JA; Leatherbarrow RJ; Tate EW; Smith DF
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3363. PubMed ID: 25522361
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines.
Manda S; Khan SI; Jain SK; Mohammed S; Tekwani BL; Khan IA; Vishwakarma RA; Bharate SB
Bioorg Med Chem Lett; 2014 Aug; 24(15):3247-50. PubMed ID: 24980054
[TBL] [Abstract][Full Text] [Related]
13. Squalamine analogues as potential anti-trypanosomal and anti-leishmanial compounds.
Khabnadideh S; Tan CL; Croft SL; Kendrick H; Yardley V; Gilbert IH
Bioorg Med Chem Lett; 2000 Jun; 10(11):1237-9. PubMed ID: 10866389
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines.
Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B
Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro antikinetoplastid activity of polyamine-hydroxybenzotriazole conjugates.
Jagu E; Pomel S; Diez-Martinez A; Ramiandrasoa F; Krauth-Siegel RL; Pethe S; Blonski C; Labruère R; Loiseau PM
Bioorg Med Chem; 2017 Jan; 25(1):84-90. PubMed ID: 27793448
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of oxysterols and nitrogenous sterols with antileishmanial and trypanocidal activities.
Bazin MA; Loiseau PM; Bories C; Letourneux Y; Rault S; El Kihel L
Eur J Med Chem; 2006 Oct; 41(10):1109-16. PubMed ID: 16949702
[TBL] [Abstract][Full Text] [Related]
17. Antikinetoplastid activity of 3-aryl-5-thiocyanatomethyl-1,2,4-oxadiazoles.
Cottrell DM; Capers J; Salem MM; DeLuca-Fradley K; Croft SL; Werbovetz KA
Bioorg Med Chem; 2004 Jun; 12(11):2815-24. PubMed ID: 15142541
[TBL] [Abstract][Full Text] [Related]
18. Novel bisbenzimidazoles with antileishmanial effectiveness.
Mayence A; Pietka A; Collins MS; Cushion MT; Tekwani BL; Huang TL; Vanden Eynde JJ
Bioorg Med Chem Lett; 2008 Apr; 18(8):2658-61. PubMed ID: 18367395
[TBL] [Abstract][Full Text] [Related]
19. Structure-Activity Relationships of Cinnamate Ester Analogues as Potent Antiprotozoal Agents.
Bernal FA; Kaiser M; Wünsch B; Schmidt TJ
ChemMedChem; 2020 Jan; 15(1):68-78. PubMed ID: 31697437
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy.
Martin MB; Grimley JS; Lewis JC; Heath HT; Bailey BN; Kendrick H; Yardley V; Caldera A; Lira R; Urbina JA; Moreno SN; Docampo R; Croft SL; Oldfield E
J Med Chem; 2001 Mar; 44(6):909-16. PubMed ID: 11300872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]